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Background: Diabetes has previously been linked to mental health problems in adolescents, but more recent
studies have yielded mixed findings. The aim of the current study was to compare symptoms of mental health
problems, sleep and eating disturbances in adolescents with and without Type 1 diabetes in a population based
sample.
Methods: Data were taken from the youth@hordaland study, a large population based study in Hordaland County
in Norway conducted in 2012. In all, 9883 adolescents aged 16–19 years (53% girls) provided self-reported data on
both diabetes and a range of instruments assessing mental health symptoms, including depression, anxiety,
obsessive-compulsive behaviours, hyperactivity, impulsivity, inattention, perfectionism, resilience, sleep problems
and eating behaviour.
Results: 40 adolescents were classified as having Type 1 diabetes (prevalence 0.4%). We found that adolescents
with Type 1 diabetes did not differ from their peers on any of the mental health measures.
Conclusions: This is one of the first population-based studies to examine mental health of adolescents with Type 1
diabetes. There was no evidence of increased psychopathology across a wide range of mental health measures.
These findings contradict previous studies, and suggest that Type 1 diabetes is not associated with an increased risk
of psychosocial problems.
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Type 1 diabetes in adolescence has previously been
linked to a range of psychosocial problems [1-3]. In a re-
view from 2009, Kakleas and colleagues concluded that
Type 1 diabetes in adolescents was associated with in-
creased risk of developing psychiatric disorders (10–
20%), specifically eating disturbances (8–30%) [4]. Type
1 diabetes in adolescence has also previously been linked
to a reduced quality of life [5], increased alcohol use [6],
as well as worse sleep [7]. Similarly, a meta-analyses on
children concluded that diabetic children were more
likely to experience various psychological difficulties
compared to their healthy peers [8]. However, these ef-
fects were small in magnitude, and also weaker in the
more recent studies and studies with well-matched* Correspondence: borge.sivertsen@fhi.no
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unless otherwise stated.comparison groups [8]. Furthermore, a large and well-
controlled study of 2672 adolescents (aged 10–21) with
diabetes found no differences in depressive symptoms
between adolescents with or without diabetes [9].
Still, the vast majority of studies of mental health in
adolescents with Type 1 diabetes has been in small clin-
ical studies and there is a strong need for population-
based studies to compare mental health comorbidities
among adolescents with and without Type 1 diabetes.
Technological and medical advances in therapy have
changed the everyday life of adolescents with Type 1
diabetes dramatically the last decade. Now 64% of
Norwegian children and adolescents use insulin pump
therapy [10]. There are some indications that recent im-
provements may also be reflected in improved mental
health [4]. Improved metabolic control may also limit
the associated cognitive and emotional problems, and
may be one pathway to improved well-being, by reducing
the daily hassles of the traditional complex diabetesal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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still psychologically complex, as improved technology does
not change the challenge of psychologically dealing with
choices such as insulin dosage and cognitive and emo-
tional reactions to high and low blood sugar levels. But
overall, life with Type 1 diabetes has changed dramatically
over the last decade, and conclusions regarding mental
health, sleep and life-style may need to be reconsidered.
Based on these considerations, the aim of the current
study was to compare symptoms of mental health
problems, sleep and eating disturbances in adolescents
with and without Type 1 diabetes in a population based
sample. Data for this study are drawn from a large
population-based survey conducted in 2012 of 9883
Norwegian adolescents aged 16–19, (the youth@hordaland
study).Methods
Design and procedure
In this population-based study, we used data from the
youth@hordaland study of adolescents in the county of
Hordaland in Western Norway. All adolescent born
between 1993 and 1995 and all students attending sec-
ondary education during spring 2012 were invited to
participate. Data were collected during spring 2012. Ad-
olescents in secondary education received information
about the study by e-mail, and time during regular
school hours was allocated to complete the question-
naire. Those not in school received information by post
to their home addresses. Also, regional hospitals were
contacted so that adolescents that were inpatients at the
time of the survey had the opportunity to participate.Ethics
The study was approved by the Regional Committee for
Medical and Health Research Ethics (REC) in Western
Norway. In accordance with the regulations from the
REC and Norwegian health authorities, adolescents aged
16 years and older can make decisions regarding their
own health (including participation in health studies),
and thus gave consent themselves to participate in the
current study. Parents/guardians have the right to be in-
formed, and in the current study, all parents/guardians
received written information about the study in advance.Sample
A total of 19,439 adolescents were invited to participate
in the survey, of whom 10,254 agreed. Of this number,
371 adolescents were omitted due to missing data on the
instruments relevant for the current study. This yielded
a total sample size of 9,883, representing a participation
rate of 51%.Instruments
Demographical characteristics
Maternal and paternal education were reported separ-
ately with three response options; “primary school”, “sec-
ondary school”, “college or university”. Participants were
also asked whether their parents live together, and a rat-
ing of the family’s financial status was assessed by asking
how their family economy is compared to most others
(1 = “like most others”; 2=”better financial circum-
stances”, and 3=”poorer financial circumstances”.
Diabetes
All adolescents indicated if he/she had diabetes from a
checklist that included “diabetes”, “asthma”, and “other
chronic illness”. As such, this item did not specifically
differentiate between Type 1 and Type 2 diabetes. Given
a positive response on this item, the adolescents an-
swered an open-ended question were they provided the
name of all medications they were taking. These were
coded according to the Anatomical Therapeutic Chem-
ical (ATC) classification system and all mediations in the
ATC–subgroup A10A (insulins and analogues) were
classified as treatments of Type 1 diabetes, and taken as
verification of the positive response on the initial check
list. In addition, if the adolescents indicated having an-
other chronic illness on the item described above, they
completed an open-ended question where they provided
the name of that illness. In all, 828 adolescents responded
positively to this item, with the most frequently reported
illnesses being atopical dermatitis, neurological, and mus-
culoskeletal conditions.
Lifestyle behaviours
Body-mass index (BMI) was calculated from self-reported
body weight and height. Physical activity was assessed
using one item, derived from the WHO “Health be-
haviour in school-aged children study” (19): “During
the last 7 days, how many days have you been physic-
ally active for a minimum of 60 minutes)?” with re-
sponse ranging from “0” to “7” days. Problematic use
of alcohol and drugs was assessed using the CRAFFT-
questionnaire, a brief screening tool designed specific-
ally to identify adolescent problematic alcohol and
drug use in a medical care setting [11].
Depression
Depression was assessed using the short version of the
Mood and Feelings Questionnaire (SMFQ) [12]. The
SMFQ comprises 13 items assessing depressive symp-
toms rated on a 3-point Likert scale. A recent study
from the youth@hordaland study [13] yielded good psy-
chometric properties of the official Norwegian transla-
tion and supported the uni-dimensional structure as
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of the SMFQ in the current study was 0.91.
Anxiety
Symptoms of anxiety were identified using the short
form five-item version of the SCARED inventory for
anxiety disorders [14]. The short-form of the SCARED
has showed similar psychometric properties to the full
version. No validation studies have been conducted on
the Norwegian translation. The Cronbach’s alpha of the
SCARED in the current study was 0.68.
ADHD symptoms
Symptoms of inattention and hyperactivity were mea-
sured using subscales from the official Norwegian trans-
lation of the Adult ADHD Self-report Scale (ASRS) [15].
The questionnaire was originally constructed for use in
adults, but has recently been validated in adolescents
[16]. ASRS is an 18 item self-report scale, comprising 9
items on a hyperactivity-impulsivity subscale and 9 items
on an inattention-subscale. A previous validation study
has found an inconsistency-adjusted sensitivity of 1.0, a
specificity of 0.71, a positive predictive value of 0.52, and
a negative predictive value of 1.0 [17]. The Cronbach’s
alpha of the ASRS in the current study was 0.89.
Obsessive-compulsive behaviour
Obsessive-compulsive behaviour was assessed by the fol-
lowing five questions covering key aspects of obsessive
compulsive disorder, as outlined by Thompson [18]: “I
wash myself more than normal. I am afraid of infection”,
“I often have to check or control things”, “I am con-
cerned with order and symmetry”, “I must often have re-
peated assurances and answers to questions”, “I have
distressing or disturbing thoughts”. These 5 items were
rated on a three point Likert scale with response op-
tions; “not true”, “somewhat true” and “certainly true”.
The Cronbach’s alpha in the current study was 0.71.
Resilience
Resilience was assessed by the Resilience Scale for Ado-
lescents (READ) [19], which consists of 28 items rated
on a 5-point Likert scale comprising: Personal Compe-
tence, Social Competence, Structured Style, Family Co-
hesion and Social Resources. The READ has shown
adequate psychometric properties [20]. The Chronbach’s
alpha of the READ in the current study was 0.95.
Eating disturbances
Eating disturbances was assessed by the Eating Disturb-
ance Scale (EDS-5) [21], a brief screening instrument for
problematic eating in normal populations. The EDS-5
has been shown to have good concurrent and construct val-
idity, and a sensitivity and specificity of 0.90 and 0.88 withrespect to DSM-IV eating disorders [21]. The Cronbach’s
alpha of the EDS-5 in the current study was 0.75.
Perfectionism
Perfectionism was assessed by the short version of the
Perfectionism subscale from the Eating Disorder Inven-
tory (EDI) [22]. The scale was adapted to a three points
response scale from the original 6-point scale for this
study. The Chronbach’s alpha of the EDI in the current
study was 0.73.
Sleep variables
Self-reported bedtime and rise time were indicated in
hours and minutes and were reported separately for week-
ends and weekdays. Time in bed (TIB) was calculated by
subtracting bedtime from rise time. Sleep onset latency
(SOL) and wake after sleep onset (WASO) were indicated
in hours and minutes, and sleep duration was defined as
TIB minus (SOL +WASO). Sleep efficiency was calculated
as sleep duration divided by TIB multiplied by 100 (re-
ported as percentage). Subjective sleep need was reported
in hours and minutes, and sleep deficiency was calculated
separately for weekends and weekdays, subtracting total
sleep duration from subjective sleep need.
Insomnia was operationalized according to the DSM-V
criteria for insomnia: self-reported difficulties initiating
and maintaining sleep for at least three times a week,
with a duration of three months or more, as well as
tiredness or sleepiness on at least three days per week.
A variable assessing symptoms of obstructive sleep
apnoea was also created based on the following two
items: 1) “I snore (or someone else says I snore)” (“true”
or “partly true”), and 2) reports of “sleepiness” at least
three days per week.
Subjective health complaints
Subjective health complaints were measured using five
items from the thoroughly validated HBSC (Health Be-
haviour in School-aged Children) symptom checklist
[23]. Participants reported the experienced frequency of
headache, abdominal pain, back pain, dizziness and pain
in neck/shoulders experienced during the last six months
on a five-point scale ranging from “more or less every day”
to “seldom or never”.
Statistics
IBM SPSS Statistics 21 for Mac (SPSS Inc., Chicago, Ill)
was used for all analyses. Pearson’s chi-square tests and
Mann–Whitney U-tests were used to examine differ-
ences in demographical, clinical and sleep variables in
adolescents with and without diabetes. Between-group
effect sizes (pooled SD) were calculated using the
Cohen’s d formula. As the control group also comprised
adolescents with chronic other illnesses (n = 828), all
Table 1 Demographical characteristics and lifestyle
behaviours in adolescents with and without Type 1 diabetes
in the youth@hordaland study (n = 9,883)
No diabetes
(n = 9,843)
Type 1 diabetes
(n = 40)
%/median (SD) %/median (SD) P -value*
Demographical
characteristics
Age, mean 19.9 0.7 19.9 0.8 .48
Gender .75
Girls, % 53.3% 50.0%
Boys, % 46.7% 50.0%
Vocational situation .64
In high school 97.8% 100%
Trainee 1.5% 0%
Not in high school 0.8% 0%
Maternal education, % .49
University/college 48.7% 50.6%
High school 41.3% 43.8%
Primary school 10.1% 15.6%
Paternal education, % .84
University/college 43.1% 38.7%
High school 46.4% 51.6%
Primary school 10.6% 9.7%
Parents live together, %
No 32.7% 25.6% .40
Family economy .28
Approx. like most others 67.4% 57.5%
Better economy 25.5% 30.0%
Poorer economy 7.1% 12.5%
Lifestyle behaviours
Current smoker 13.2% 15.0% .64
CRAFFT sum score 0.8 (1.2) 0.9 1.3 .54
Physical activity
(days/wk), %
.52
None 9.9% 15.4%
1-3 days 49.7% 46.2%
4 + days 40.4% 38.5%
Body-mass index 22.2 3.5 23.2 3.1 .03
*P value is based on Mann–Whitney U tests.
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uals form the control group. This, however, did not
change the results or conclusions in any way, and there-
fore the control group used in current study includes all
adolescents not reporting diabetes.
Results
Demographical and clinical characteristics
The mean age of the sample was 17.9 years (range 16–
19), and included more girls (53.3%) than boys (46.7%).
The vast majority (98%) were high school students. The
prevalence rate of Type 1 diabetes was 0.4% in both boys
(n = 20) and girls (n = 20). Table 1 shows that there were
no significant differences between adolescents with and
without Type 1 diabetes in terms of maternal or paternal
education, and neither family financial nor co-habitant
status differed significantly between the two groups.
Type 1 diabetes and lifestyle behaviours
No significant differences were found between the Type 1
diabetes versus non-diabetes group in terms of smoking
(P = .64) or problematic alcohol or drug use (P = .54). The
proportion of adolescents with Type 1 diabetes who were
physically active 4 days or more per week did not differ
from the non-diabetes group (38.5% and 40.4%). However,
it should be noted that as many as 15.4% of adolescents
with Type 1 diabetes (and 9.9% in the non-diabetes group)
did not perform any physical activity during the week,
although this difference was not statistical significant
(P = .52). The mean BMI in the Type 1 diabetes group
was significantly higher than in the non-diabetes group
(23.2 versus 22.2, P = .03).
Type 1 diabetes and mental health symptoms
Table 2 shows the mean symptom levels across all health
instruments in the Type 1 diabetes and non-diabetes
groups. In terms of mental health problems, the adoles-
cents with Type 1 diabetes did not report higher levels on
any of the assessed instruments; including depression, anx-
iety, obsessive compulsivity, ADHD-symptoms, and per-
fectionism. The Cohen’s d effect sizes were small, ranging
from .00 to .16. The same pattern was found for resilience.
No significant differences between the Type 1 diabetes and
non-diabetes groups were identified for any of the 5 sub-
scales, with small effect sizes ranging from .09 to .27.
Type 1 diabetes and eating disturbance
In terms of eating disturbances, having Type 1 diabetes
was not associated with elevated scores on the EDS total
score. However, as shown in Figure 1, one of the items
in the EDS scale differed between the two groups: a
larger proportion of adolescents with Type 1 diabetes re-
ported needing a strict diet to control their eating com-
pared to the non-diabetes group (effect size .31, P = .017).Type 1 diabetes and sleep problems
Adolescents with Type 1 diabetes did not differ in terms
of their reported sleep problems compared to the non-
diabetes group on any of the assessed sleep parameters.
Neither sleep duration, sleep efficiency, sleep deficiency,
SOL nor WASO, differed between the two groups. Simi-
larly, the prevalence of insomnia and OSA was not
Table 2 Health characteristics in adolescents with and without Type 1 diabetes in the youth@hordaland study (n = 9,883)
No diabetes (n = 9,843) Type 1 diabetes (n = 40)
%/mean (SD) %/mean (SD) P-value* Cohen’s d
Mental health
Depression (SMFQ Total score) 5.8 5.8 6.5 5.8 .28 .12
Anxiety (SCARED Total score) 1.5 1.8 1.7 1.8 .53 .11
OCD (OCD Total score) 2.4 2.2 2.4 2.3 .71 .00
Hyperact./imp. (ASRS subscale) 11.8 5.4 12.9 6.1 .40 .19
Inattention (ASRS subscale) 15.0 6.2 15.5 6.5 .99 .08
Perfectionism (EDI Total score) 4.6 2.7 4.3 2.7 .55 .11
Eating disturbances (EDS Total score) 3.2 2.3 3.6 2.8 .62 .16
Resilience
Personal competence 30.1 6.1 28.8 6.5 .22 .21
Personal structure 14.0 3.2 13.7 3.2 .53 .09
Social competence 19.5 4.1 18.4 3.9 .07 .27
Social support 21.5 3.5 20.7 4.4 .31 .20
Family cohesion 2.9 5.1 2.3 5.7 .35 .11
Sleep
Sleep duration 6:25 1:39 6:18 1:37 .63 .07
Sleep efficiency 85.3 17.7 87.0 18.2 .57 .09
Sleep deficiency 2:09 2:30 2:19 2:25 .88 .07
Sleep onset latency 0:47 0:57 0:52 1:22 .69 .07
Wake after sleep onset 0:15 0:39 0:03 0:07 .26 .43
Insomnia (DSM-V) 18.5% 11.1% .39 .69
Obstructive sleep apnoea (OSA) 4.1% 6.9% .34 .16
Somatic health
HSBC Total score 4.9 4.7 6.5 5.6 .08 .31
*P value is based on Mann–Whitney U tests.
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betes, compared to the control group.
Type 1 diabetes and subjective health complaints
No significant group differences were found on the HSBC
total score, although there was a trend for adolescents
with Type 1 diabetes to report more somatic complaints
than adolescents without Type 1 diabetes (6.5 versus 4.9,
respectively: effect size .31; P = .08). Analyses of each of
the 5 specific complaints showed that the Type 1 diabetes
group reported significantly more back pain (P = .02) than
the control group, whereas, no group differences were
found for the remaining 4 items (headache, neck and
shoulder pain, abdominal pain, and dizziness).
No significant gender differences were found for any of
measures.
Discussion
The aim of this population-based study from was to
compare mental health symptoms, sleep problems,
health behaviours and eating disturbances in adolescentswith and without Type 1 diabetes. We found adolescents
with Type 1 diabetes did not differ from adolescents
without Type 1 diabetes on any of the instruments used
in the current study: Type 1 diabetes was not associated
with elevated symptoms of mental health problems,
sleep problems, eating disorders nor health behaviours.
The results are in contrast to the elevated level of
mental health problems and disturbed eating behaviour
found in previous research [4,24]. While methodological
differences may explain some of the discrepancies, it
may also reflect recent changes in the management of
diabetes. While studies from the 1990s reported that gly-
caemic control often deteriorated during adolescence
[25], the recent rapid adoption of diabetes-pump ther-
apy, especially among children and adolescents, has
shown promising results with regards to fewer instances
of severe hypoglycaemia, lower HbA1c levels, low risk of
ketoacidosis, as well as less glucose fluctuations [26]. It
is possible that this improvement in control of diabetes
is reflected in mental health, although the current study
did not specifically examine the use of insulin pumps.
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Figure 1 Eating problems among adolescents with and without Type 1 diabetes in the youth@hordaland study. Vertical axis represents
proportion of adolescents answering “true” or “partly true” on each of the 5 EDS items. Error bars represent 95% confidence intervals. P-values are
based on Chi-squared tests, and Cohen’s d effect sizes (ES) are calculated from means and standard deviation from the EDS’ original 3 response
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and adult pump-users that showed less symptoms of
anxiety and depression, as well as improved self-esteem
and locus of control after starting therapy [27]. In
addition to the direct link between mental health and ill-
ness management, psychological functioning may also be
affected indirectly through improved cognitive function.
While we have no information on how many of the
adolescents with Type 1 diabetes in the current study
were using insulin pumps, the adoption rates in Norway
are very high, and this may partly explain why so few
mental health problems were reported among the ado-
lescents with Type 1 diabetes in the current study. How-
ever, use of insulin pump is not likely to be the sole
explanation as to why no differences were found across
all the assessed domains of psychosocial functioning. In-
deed, there are mixed findings with regards to changes
in quality of life in persons with diabetes treated with
the insulin pump compared with multiple daily injec-
tions system [28]. Also, a significant proportion of
Norwegian adolescents still use more conventional insulin
regimens. As such, there may be other possible factors
that may explain why diabetic adolescents in the current
study seem to be little affected and restricted by their ill-
ness in terms of mental health functioning For example, it
is possible that having Type 1 diabetes is now less stigma-
tizing than before, and also new and improved medical
regimens and practices may allow better matching of diet
to insulin through multiple daily injections. However,
these factors were not specifically addressed in the current
study, and should be explored in future studies.The results indicate that adolescents with diabetes are
not restricted by their illness. They are as physically ac-
tive, make similar lifestyle choices and have mental
health similar to their peers. While previous studies have
found elevated levels of disturbed eating behaviours in
adolescents with Type 1 diabetes, with estimates of eat-
ing disorders ranging from 8 to 30% [4,24], we found no
evidence of disturbed eating. The stronger need for a
strict diet to control their eating reported by adolescents
with Type 1 diabetes is not surprising given the nature
of diabetes. However, the EDS-5 is not a diabetes-
specific questionnaire and it is likely that the EDS-5 is
insensitive to insulin omission/insulin purging as a
means to lose weight. Cigarette smoking has been shown
to be an independent risk factor for later medical com-
plications in Type 1 diabetes, and previous reports have
shown that around 1 in 4 adolescents smoke on a daily
basis [29]. In the current study, only 15% of the adoles-
cents with Type 1 diabetes reported to be smokers,
which is similar to both the control group as well as na-
tional surveys on current adolescent smoking. We also
found no elevated alcohol and drug problems among
Type 1 diabetes adolescents, which is important, given
that alcohol is associated with impaired ability to detect
hypoglycaemic symptoms. One explanation for these
non-significant findings may be the corresponding lack
of group differences in mental health problems, which
previously has been shown to contribute to the initiation
of such adverse lifestyle behaviours in diabetes [30]. Of
interest is the fact that 15% of adolescents with Type 1
diabetes reported no physical activity at all during the
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trol group (10%), this figure is disturbingly high, as indi-
viduals with Type 1 diabetes face increased risk of
cardiovascular diseases, and regular exercise can help re-
duce these risks. Furthermore, while the rates of mental
health issues may not be necessarily elevated in compari-
son to healthy peers, the implications for untreated men-
tal health disorders in adolescents with chronic illness is
significant and even normative levels of psychopathology
should be identified given the potential impact on self-
care behaviors and health.
Although changes in sleep duration and patterns are
well documented in adolescence [31], there is a paucity
of studies describing sleep and sleep problems among
adolescents with Type 1 diabetes. This is surprising
given the relevance of sleep stability in optimizing insu-
lin treatment regimens [7]. In a clinical study of 75 ado-
lescent with Type 1 diabetes, the sleep duration in the
Type 1 diabetes group was significantly longer than
healthy peers (8.5 hrs vs. 8.0 hrs., respectively). Having
Type 1 diabetes was also associated with larger discrep-
ancies between weekends and weekdays [7]. In contrast,
the current study found no evidence of altered sleep
duration or higher levels of sleep problems.
Study limitations
There are some methodological limitations of the present
study that should be noted. Firstly, the measurement of
Type 1 diabetes was based on self-report, and the rela-
tively small number of adolescents with Type 1 diabetes
(40 individuals) is a limitation. The adolescent indicated if
he/she had diabetes from a checklist, which comprised
several chronic illnesses, and the list did not differentiate
between Type 1 and Type 2 diabetes. However, in addition
the adolescents provided information on all medications
they were taking, and all insulins and analogues (ATC–
subgroup A10A) were classified as treatments of Type 1
diabetes, and thereby verifying a likely diagnosis. None of
the adolescents indicated taking antidiabetic drugs (other
than insulin: ATC-subgroup A10B), making it very un-
likely that adolescents with Type 2 being were included in
the diabetes group. However as adolescents with Type 2
diabetes also may take insulin, we cannot completely rule
out the possibility of misclassification. Also, the prevalence
of Type 1 diabetes in the current study (0.4%) corresponds
well with what has been reported for this age group on a
national level in Norway [32]. Still, no clinician verified
diagnosis or physiological assessments of blood glucose
level or HbA1c were available, and although such assess-
ments are rarely available in large epidemiological studies,
the current results should thus be interpreted with cau-
tion. Also, the fact that we had no information on use of
diabetes technology data limits the ability to investigate
whether newer technology (such as new generation ofinsulin pumps) may be related to mental health function-
ing. Furthermore, attrition from the study could affect
generalizability, with a response rate of about 51% and
with adolescents in schools overrepresented. Official data
show that in 2012, 92% of all adolescents in Norway aged
16–18 attended high school [33], compared to 98% in the
current study. In addition, all 40 adolescents with Type 1
diabetes reported being in high school. As worse health
typically increases the risk of being a non-attender in epi-
demiological studies, it is possible that adolescents with
Type 1 diabetes with poor glycaemic control and psychi-
atric comorbidity might be underrepresented in the
current study. Finally, the youth@hordaland study mainly
consists of ethnic Norwegians, and the lack of ethic diver-
sity together with the limited age span (16–19 yrs.) may
limit the generalizability to other ethnicities and age
groups.
Conclusions
We conclude that there was no evidence of increased
psychopathology across a wide range of mental health
measures. These findings contrast with earlier studies,
and suggest that Type 1 diabetes is not associated with
an increased risk of psychosocial problems.
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